Intracranial Disease in Patients with Non-Small Cell Lung Cancer: Treatment with Erlotinib
Keywords brain metastases, non-small cell lung cancer, EGFR sensitizing mutation, tyrosine kinase inhibitors, erlotinib Outline Introduction 170 First-Line Treatment for Advanced NSCLC 170 Development and Management of NSCLC Brain…